On the other hand, a study focusing on the type 1 diabetes NOD mouse model, and assessing granzyme B and IFN-γ production as markers of CD8+ and CD4+ T-cell activation following MERTK inhibition with UNC2025 challenge, found incomplete penetrance. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.